Stocks and Investing Stocks and Investing
Tue, November 22, 2022
Mon, November 21, 2022

Debjit Chattopadhyay Maintained (ALLO) at Strong Buy with Decreased Target to $29 on, Nov 21st, 2022


Published on 2024-10-28 00:17:07 - WOPRAI, Debjit Chattopadhyay
  Print publication without navigation
Debjit Chattopadhyay of HC Wainwright & Co., Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Decreased Target from $43 to $29 on, Nov 21st, 2022.

Debjit has made no other calls on ALLO in the last 4 months.



There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 1 agrees with Debjit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Dane Leone of "Raymond James" Downgraded from Buy to Hold on, Wednesday, August 10th, 2022


These are the ratings of the 3 analyists that currently disagree with Debjit


  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, September 22nd, 2022
  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $32 on, Wednesday, August 10th, 2022
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 10th, 2022
Contributing Sources